An experimental drug has shown promise in preventing Alzheimer’s for people at higher risk of developing the disease.
An experimental treatment appears to delay Alzheimer's symptoms in some people genetically destined to get the disease in ...
New research suggests that blood tests used to diagnose Alzheimer's disease have racial disparities. Here's what's going on ...
An experimental treatment appears to delay Alzheimer’s symptoms in some people genetically destined to get the disease in ...
CervoMed's stock soars 400% on promising dementia drug data. See more on insights, potential concerns, and what it means for ...
The research group led by Prof. Wang Chu from the College of Chemistry and Molecular Engineering at Peking University ...
Using a novel quantitative chemoproteomic strategy, a research group led by Prof. Wang Chu from the College of Chemistry and ...
For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from the brains<a class="excerpt-read-more" href=" More ...
Enigma Biomedical USA Inc. has selected two four-repeat tau (4R tau) protein PET imaging biomarkers to advance into phase I studies. These imaging biomarkers show promise as important new tools in ...
A new study has found that women with high levels of β-amyloid (Aβ), a protein linked to Alzheimer’s disease, experience ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback